Second Chance for Moms Act

Bill: 119-hr-796
Sponsor: full_name: Rep. Miller, Mary E. [R-IL-15]
Introduced: 2025-01-28
Policy area: Health
Subjects: Abortion

Consumer affairs

Prescription drugs

Sex and reproductive health

Telephone and wireless communication

Women's health
Latest action: action_date: 2025-01-28
text: Referred to the House Committee on Energy and Commerce.

Summaries:
action_date: 2025-01-28
action_desc: Introduced in House
text: <p><strong>Second Chance for Moms Act of 2025</strong></p><p>This bill requires labeling of the drug mifepristone to include certain information about the hormone progesterone and establishes a related telephone hotline. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.)</p>

tv_txt: I 119th CONGRESS 1st Session H. R. 796 IN THE HOUSE OF REPRESENTATIVES January 28, 2025 Mrs. Miller of Illinois (for herself, Mr. Babin , Mr. Moore of Alabama , Mr. Moore of West Virginia , Mr. Ogles , Mr. Webster of Florida , Ms. Tenney , Mr. Clyde , Mr. Harris of Maryland , and Mr. Weber of Texas ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend the Federal Food, Drug, and Cosmetic Act to require a warning label advising that the effects of mifepristone can be counteracted, to amend the Public Health Service Act to establish a hotline to provide information to women seeking to counteract the effects of mifepristone, and for other purposes.

1. Short title This Act may be cited as the Second Chance for Moms Act of 2025 . 2. Mifepristone warning label and hotline (a) Warning label (1) In general Section 502 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 352 ) is amended by adding at the end the following: (hh) If it is the drug mifepristone, and its labeling does not bear the following statement printed in conspicuous text: WARNING: Medical evidence suggests that the abortifacient effects of mifepristone can be counteracted by natural progesterone, which can increase the chance of fetal survival. The American Society for Reproductive Medicine has determined that natural progesterone is safe in the first trimester of pregnancy. For more information, call [___]. (with the blank filled in to refer to the appropriate number for the hotline under section 1009 of the Public Health Service Act). . (2) Effective date Section 502(hh) of the Federal Food, Drug, and Cosmetic Act (as added by paragraph (1)) applies beginning on the date that is 6 months after the date of enactment of this Act. (b) Hotline Title X of the Public Health Service Act ( 42 U.S.C. 300 et seq. ) is amended by adding at the end the following: 1009. Hotline for reversal of effects of mifepristone (a) In general The Secretary shall establish or maintain, directly or by grant or contract, a toll-free hotline to provide support for 24 hours a day, 7 days a week, for women seeking to reverse the effects of the drug mifepristone. (b) Referrals to APR providers only A referral through the hotline described in subsection (a) may only be made to a health care provider that provides abortion pill reversal services. .